Sildenafil Powder,

FDA Drug Profile — Sildenafil

Sildenafil Powder, is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Sildenafil. Available dosage form: for suspension.

Drug details

Generic Name
Sildenafil Powder,
Brand Names
Sildenafil
Application Number
ANDA213014
Sponsor
Camber Pharmaceuticals, Inc.
NDC Codes
1
Dosage Forms
FOR SUSPENSION
Routes
ORAL
Active Ingredients
SILDENAFIL CITRATE

Indications and Usage

1 INDICATIONS AND USAGE Adults Sildenafilfororal suspension is indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening [ see Clinical Studies (14 )] . Pediatric use information is approved for Viatris Specialty LLC's, REVATIO (sildenafil) for oral suspension. However, due to Viatris Specialty LLC's marketing exclusivity rights, this drug product is not labeled with that information. Adults Sildenafil for oral suspension is a phosphodiesterase-5 (PDE-5) inhibitor indicated for the treatment of pulmonary arterial hypertension (PAH) (World Health Organization [WHO] Group I) in adults to improve exercise ability and delay clinical worsening. (1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.